Argenx Patents – Insights & Stats

Argenx has a total of 202 patents globally, out of which 67 have been granted. Of these 202 patents, more than 76% patents are active. The United States of America is where Argenx has filed the maximum number of patents, followed by Europe and Australia. Parallelly, The United Kingdom seems to be the main focused R&D center and also Netherlands is the origin country of Argenx.

Argenx was founded in 2008. The Company operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer.

Do read about some of the most popular patents of Argenx which have been covered by us in this article and also you can find Argenx patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Argenx patent portfolio.

How many patents does the Founder and CEO of Argenx have?

The Founder and the CEO Tim Van Hauwermeiren has 38 patents.

How many patents does Argenx have?

Argenx has a total of 202 patents globally. These patents belong to 47 unique patent families. Out of 202 patents, 154 patents are active.

How Many Patents did Argenx File Every Year?

Argenx Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantArgenx Applications FiledArgenx Patents Granted
202343
20222226
2021307
2020154
2019193
2018254
201747
201697
2015131
2014183
2013192
20127

How many Argenx patents are Alive/Dead?

Worldwide Patents

Argenx Patent Portfolio

 How Many Patents did Argenx File in Different Countries?

Argenx Worldwide Patent Filing

Countries in which Argenx Filed Patents

CountryPatents
United States Of America49
Europe13
Australia12
New Zealand10
Canada9
United Kingdom9
India9
Singapore8
Israel6
South Africa5
Brazil5
Mexico5
Indonesia5
Hong Kong (S.A.R.)4
Japan3
Spain2
Hungary2
Chile2
Italy2
Norway2
Serbia1
Croatia1
Slovenia1
Austria1
Poland1
Taiwan1
Germany1
Colombia1
Slovakia1
Peru1
Philippines1
Denmark1
Korea (South)1
Ecuador1
Lithuania1

Where are Research Centers of Argenx Patents Located?

R&D Centers of Argenx

 10 Best Argenx Patents

WO2011080350A1 is the most popular patent in the Argenx portfolio. It has received 55 citations so far from companies like Evec Co. Ltd, Cardio3 Biosciences S.A. and Staten Biotechnology B.V.

Below is the list of 10 most cited patents of Argenx:

Publication NumberCitation Count
WO2011080350A155
WO2016125017A139
WO2016026943A138
WO2012123586A136
WO2015100299A133
WO2012059561A130
US8834882B227
WO2012059562A125
WO2014033252A124
US9765148B222

What Percentage of Argenx US Patent Applications were Granted?

Argenx (Excluding its subsidiaries) has filed 46 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 32 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Argenx patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Argenx?

Law FirmTotal ApplicationsSuccess Rate
Lathrop Gpm25100.00%
Dechert21100.00%

hat are Argenx key innovation segments?

What Technologies are Covered by Argenx?

The chart below distributes patents filed by Argenx in different countries on the basis of the technology protected in patents. It also represents the markets where Argenx thinks it’s important to protect particular technology inventions.

R&D Focus: How has Argenx search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Argenx?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.